ストックスクリーナーアプリを入手
1.53
4.79%
0.07
アフターアワーズ：
1.53
前日終値:
$1.46
開ける：
$1.48
24時間の取引高:
224.64K
Relative Volume:
0.85
時価総額：
$46.01M
収益：
$210.70K
当期純損益:
$-21.37M
株価収益率:
-1.3909
EPS:
-1.1
ネットキャッシュフロー:
$-21.10M
1週間 パフォーマンス:
-8.38%
1か月 パフォーマンス:
-11.56%
6か月 パフォーマンス:
-39.04%
1年 パフォーマンス:
+63.03%
1日の値動き範囲:
$1.46
$1.54
1週間の範囲:
$1.45
$1.68
52週間の値動き範囲:
$0.89
$3.19
Gain Therapeutics Inc Stock (GANX) Company Profile
GANX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
1.53 | 50.47M | 210.70K | -21.37M | -21.10M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2024-12-06 | 開始されました | ROTH MKM | Buy |
| 2024-08-14 | 再開されました | Oppenheimer | Outperform |
| 2021-04-12 | 開始されました | BTIG Research | Buy |
| 2021-04-12 | 開始されました | Oppenheimer | Outperform |
Gain Therapeutics Inc (GANX) 最新ニュース
Gain Therapeutics Inc.’s Price Action Aligns with Quant SignalsReal-Time Analysis With Entry Targets In Progress - 선데이타임즈
Gain Therapeutics Fast-Tracks Parkinson's Drug Trial: Key Results Coming Q4 2025, Raises $7.1M - Stock Titan
What analysts say about Gain Therapeutics Inc. stock outlookAI Model Forecasting Reversal and Breakout Zones - Newser
Is Gain Therapeutics Inc. forming a reversal patternReal Time Screener for Growth Trades - Newser
Gain Therapeutics GANX 2025Q2 Earnings Preview Upside Potential on Robust Revenue Growth - AInvest
Using flow based indicators on Gain Therapeutics Inc.Low Risk High Confidence Watchlist Builder - Newser
Analyzing recovery setups for Gain Therapeutics Inc. investorsTrade Safety Report with Pattern Insights - Newser
Candlestick signals on Gain Therapeutics Inc. stock todayPrice Action Based Buy Zone Forecast - Newser
Has Gain Therapeutics Inc. found a price floorFree Buy Signal Based on Chart Analysis - Newser
Healthcare Stocks in Focus: Gainers and Losers in Friday's After-Market Session - AInvest
Why Gain Therapeutics Inc. stock attracts strong analyst attentionFree Safe Entry Stock Watch Suggestions - Newser
Visualizing Gain Therapeutics Inc. stock with heatmapsConsistent Return Setup with Exit Strategy - Newser
Best data tools to analyze Gain Therapeutics Inc. stockGrowth Watchlist for Long Term Positioning - Newser
Gain Therapeutics, Inc. (NASDAQ:GANX) Receives $8.20 Average Target Price from Analysts - Defense World
Gain Therapeutics (GANX) Projected to Post Earnings on Thursday - Defense World
What makes Gain Therapeutics Inc. stock price move sharplyGrowth Summary Based on Market Positioning - Newser
Gain Therapeutics Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
What technical models suggest about Alaunos Therapeutics Inc.’s comebackWeekly Signal Report with Trend Summary - Newser
What is the dividend policy of Gain Therapeutics Inc. stockConsistent wealth multiplication - Jammu Links News
Should I hold or sell Gain Therapeutics Inc. stock in 2025Discover breakthrough investment opportunities - Jammu Links News
Is Gain Therapeutics Inc. a good long term investmentAchieve breakthrough financial results today - Jammu Links News
Is Gain Therapeutics Inc. stock overvalued or undervaluedMaximize returns with disciplined trading approaches - Jammu Links News
What catalysts could drive Gain Therapeutics Inc. stock higher in 2025Capitalize on high-yield stocks early - Jammu Links News
Evaluating Gain Therapeutics Inc. with trendline analysisPortfolio Review Summary with Five-Year Outlook - Newser
What are analysts’ price targets for Gain Therapeutics Inc. in the next 12 monthsHigh-velocity gains - Jammu Links News
How does Gain Therapeutics Inc. compare to its industry peersAccelerated capital growth - Jammu Links News
How does Gain Therapeutics Inc. generate profit in a changing economyConsistent triple returns - Jammu Links News
What are the latest earnings results for Gain Therapeutics Inc.Free Bull & Bear Market Updates - Jammu Links News
Gain Therapeutics Inc (GANX) 財務データ
収益
当期純利益
現金流量
EPS
0.91%
3.06%
大文字化:
|
ボリューム (24 時間):